KTTA
Pasithea Therapeutics Corp.$0.68-0.01 (-1.06%)Prev Close$0.69·MCap$6.0M·P/E—·Vol73.6K·Yield—
▲
Buys (12M)
2
$125.0K
▼
Sells (12M)
1
$792.00
◆
Net Activity
Net Buyer
$124.2K
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Pasithea Therapeutics Corp. (KTTA) has been dominated by buying, with 2 insider purchases totaling $125.0K and 1 insider sale totaling $792.00. The most recent insider transaction was by Marques Tiago (Chief Executive Officer), who purchased $25.0K worth of shares on Nov 28, 2025. Pasithea Therapeutics Corp. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.0M.
KTTA Insider Trading Activity
KTTA Insider Buying Activity
The following table shows recent insider purchases of Pasithea Therapeutics Corp. (KTTA) stock reported via SEC Form 4 filings.
KTTA Insider Selling Activity
The following table shows recent insider sales of Pasithea Therapeutics Corp. (KTTA) stock reported via SEC Form 4 filings.